“These articles contributed to widespread prescription of hormones to women who did not need them, but who were put at risk of blood clots, breast cancer, and other adverse effects.”

Adriane Fugh-Berman, of Georgetown University Medical Center, comments on the latest pharma industry ghost-writing story (Milwaukee-Wisconsin Journal Sentinel).

“The bottom line is that the authors of the articles in question exercised substantive editorial control over the content of the articles and had the final say, in all respects, over the content – all of which was scientifically accurate.”

Doug Petkus, of Wyeth, puts his side of the argument (Milwaukee-Wisconsin Journal Sentinel).

“We had 11 management levels in research and development and you had to dig down quite a few before you found anyone doing research. We need to reconfigure. We’ve just been tweaking things. We have to change how people think and interact.”

Chris Viehbacher, chief executive of Sanofi-Aventis, explains some of the changes he’s been making (Financial Times, via Pharmagossip).

“Of course there are extra costs. But if we want to preserve Antarctica as pristine as possible, we need to take [on] the costs.”

Fredrik Gröndahl of the Royal Institute of Technology in Stockholm, comments on his research highlighting deficiencies in the sewage systems of Antarctic research bases (The Scientist).